---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-026352"
form_type: "8-K"
ticker: "GBCS"
cik: "0000727346"
company_name: "SELECTIS HEALTH, INC."
filed_at: "2022-09-20T23:59:59+00:00"
generated_at: "2026-06-23T08:39:15.201434+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago

## Summary
- Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.
- Q1 2022 revenue $10.1M, up 75% YoY; net income $0.2M ($0.07 per share) vs $0.2M.
- Company became current on SEC filings by filing Q1 and Q2 2022 10-Qs, resolving prior delays.
- Appointed Christine Lucus as CFO and David Furstenberg to board; cash $3.9M at June 30, 2022.
- Operating cash flow improved to $0.1M for six months ended June 30, 2022 vs ($0.6M) year ago.

## SEC filing metadata
- accession: 0001493152-22-026352
- form_type: 8-K
- ticker: GBCS
- cik: 0000727346
- company_name: SELECTIS HEALTH, INC.
- filed_at: 2022-09-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/0001493152-22-026352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-026352
- JSON: https://secwatch.observer/filing/0001493152-22-026352.json
- Plain text: https://secwatch.observer/filing/0001493152-22-026352.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.